PTGS2 and Alzheimer disease: These last findings, along with the evidence that elevated levels of proinflammatory PGD2 and PGF2α were detected in both blood and CSF samples from MCI patients, supports the hypothesis of an early involvement of COX-2 and its products, making this enzyme a potential biomarker for early diagnosis of AD [144,145].